BELENA DAVIS: Open Payments
NPI 1598074361 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 59 payments from 16 companies in 2025. Trend: 2023 $777 · 2024 $898 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $322 |
| ABBVIE INC. | 15 | $190 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $144 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Daiichi Sankyo Inc. | 2 | $48 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $43 |
| Lundbeck LLC | 2 | $29 |
| Ardelyx, Inc. | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: Wegovy, LifeVest, Ozempic, QULIPTA, UBRELVY, Auvelity, INJECTAFER, VRAYLAR.
Industry payments across TN — which companies pay providers there.
